These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10491869)

  • 21. Lack of immunity in university students before an outbreak of serogroup C meningococcal infection.
    Jones GR; Williams JN; Christodoulides M; Jolley K; Heckels JE
    J Infect Dis; 2000 Mar; 181(3):1172-5. PubMed ID: 10720549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the burden of serogroup C meningococcal disease in England and Wales.
    Davison KL; Ramsay ME; Crowcroft NS; Lieftucht A; Kaczmarski EB; Trotter CL; Gungabissoon U; Begg NT
    Commun Dis Public Health; 2002 Sep; 5(3):213-9. PubMed ID: 12434691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of meningococcal outbreaks: are we using the same language? Comparison of the public health policies between high-income countries with low incidence of meningococcal disease.
    Burmaz T; Guicciardi S; Selle V; Lopalco PL; Baldo V; Fantini MP
    Expert Rev Vaccines; 2019 May; 18(5):559-574. PubMed ID: 30875482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An outbreak of meningococcal disease: implications for community medicine.
    Buchan H; Levy L; McLeod JW; Say J
    N Z Med J; 1984 Dec; 97(769):860-2. PubMed ID: 6440068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serological correlates of protection against meningococci in a cohort of university students, before and during an outbreak of serogroup C infection.
    Williams JN; Jones GR; Christodoulides M; Heckels JE
    J Infect Dis; 2003 May; 187(9):1433-41. PubMed ID: 12717625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serogroup B meningococcal disease during Hajj: preparing for the worst scenario.
    Khalil MK; Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):231-4. PubMed ID: 19717106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serogroup C meningococcal outbreaks in the United States. An emerging threat.
    Jackson LA; Schuchat A; Reeves MW; Wenger JD
    JAMA; 1995 Feb; 273(5):383-9. PubMed ID: 7823383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cluster of meningococcal diseases in Allgaeu -- strategies for intervention].
    Hautmann W; Harms I; Vogel U; Zirngibl A; Wildner M
    Gesundheitswesen; 2005 Dec; 67(12):853-7. PubMed ID: 16379047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and meningococcal serogroup distribution in the United States.
    Hershey JH; Hitchcock W
    Clin Pediatr (Phila); 2010 Jun; 49(6):519-24. PubMed ID: 20507868
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines.
    Oviedo-Orta E; Ahmed S; Rappuoli R; Black S
    Vaccine; 2015 Jul; 33(31):3628-35. PubMed ID: 26093201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New guidelines for management and prevention of meningococcal disease in Australia. Meningococcal Disease Working Party of the National Health and Medical Research Council.
    Patel MS; Collignon PJ; Watson CR; Condon RJ; Doherty RR; Merianos A; Stewart GJ
    Med J Aust; 1997 Jun; 166(11):598-601. PubMed ID: 9201182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serogroup W135 meningococcal disease in Hajj pilgrims.
    Taha MK; Achtman M; Alonso JM; Greenwood B; Ramsay M; Fox A; Gray S; Kaczmarski E
    Lancet; 2000 Dec 23-30; 356(9248):2159. PubMed ID: 11191548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using the national guidelines to manage a meningococcal group C outbreak in a Brisbane boarding school--some discretionary judgements are needed.
    Davison RP; Lovegrove DR; Selvey LA; Smith HV
    Commun Dis Intell Q Rep; 2003; 27(4):520-3. PubMed ID: 15508510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing meningococcal disease in higher education institutions.
    Commun Dis Rep CDR Wkly; 1998 Jun; 8(25):219, 222. PubMed ID: 9670608
    [No Abstract]   [Full Text] [Related]  

  • 35. Meningococcal disease, serogroup W135.
    Wkly Epidemiol Rec; 2001 May; 76(19):141-2. PubMed ID: 11383502
    [No Abstract]   [Full Text] [Related]  

  • 36. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meningococcal disease in Ironville.
    Commun Dis Rep CDR Wkly; 1999 Aug; 9(34):297. PubMed ID: 10502876
    [No Abstract]   [Full Text] [Related]  

  • 38. Delivering a safe and effective strain-specific vaccine to control an epidemic of group B meningococcal disease.
    O'Hallahan J; McNicholas A; Galloway Y; O'Leary E; Roseveare C
    N Z Med J; 2009 Mar; 122(1291):48-59. PubMed ID: 19322255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guidelines for public health management of meningococcal disease in the UK.
    ; ;
    Commun Dis Public Health; 2002 Sep; 5(3):187-204. PubMed ID: 12434689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.